Seeing Is Believing
Currently out of the existing stock ratings of Mike Polark, 75 are a BUY (64.66%), 21 are a HOLD (18.1%), 20 are a SELL (17.24%).
Analyst Mike Polark, currently employed at BAIRD, carries an average stock price target met ratio of 70.53% that have a potential upside of 14.36% achieved within 177 days. Previously, Mike Polark worked at WOLFE.
Mike Polark’s has documented 218 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 13-Aug-2026.
Analyst best performing recommendations are on TMO (THERMO FISHER SCIENTIFIC).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 9/1/2020. The price target of $220 was fulfilled within 2 days with a profit of $6.7 (2.96%) receiving and performance score of 14.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Aug-2021
$148
$-7.72 (-4.96%)
$148
5 years 14 days ago
(17-Sep-2021)
1/2 (50%)
$-2.27 (-1.51%)
31
Buy Since 21-Jan-2016
$145
5 years 23 days ago
(08-Sep-2021)
6/6 (100%)
$6.96 (5.04%)
324
Buy Since 02-Sep-2020
$150
$-5.72 (-3.67%)
$150
5 years 28 days ago
(03-Sep-2021)
5/5 (100%)
$-1.21 (-0.80%)
89
Buy Since 07-Sep-2017
$155
$-0.72 (-0.46%)
$130
5 years 2 months 1 days ago
(30-Jul-2021)
5/5 (100%)
$16.97 (12.29%)
148
Buy Since 05-Nov-2018
$122
$-33.72 (-21.65%)
$120
5 years 4 months 28 days ago
(03-May-2021)
8/8 (100%)
$11.61 (10.52%)
296
Which stock is Mike Polark most bullish on?
Which stock is Mike Polark most reserved on?
What Year was the first public recommendation made by Mike Polark?